yttrium Y 90-epratuzumab tetraxetan
Term · Oncology and biomedicine · MLC-T-ONC-009452
A substance being studied in the treatment of certain types of B-cell cancer. Epratuzumab is a monoclonal antibody that binds to a protein called CD22, which is found on the surface of B cells. It is linked to a radioactive substance called yttrium Y 90, which may help kill cancer cells. Yttrium Y 90-epratuzumab tetraxetan is a type of radioimmunoconjugate.
| Identifier | MLC-T-ONC-009452 |
|---|---|
| Field | Oncology and biomedicine |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-009452",
"term": "yttrium Y 90-epratuzumab tetraxetan",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of certain types of B-cell cancer. Epratuzumab is a monoclonal antibody that binds to a protein called CD22, which is found on the surface of B cells. It is linked to a radioactive substance called yttrium Y 90, which may help kill cancer cells. Yttrium Y 90-epratuzumab tetraxetan is a type of radioimmunoconjugate.",
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/yttrium-y-90-epratuzumab-tetraxetan/"
}
Record 17,584 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.